Alzheimer's disease & dementia

New Alzheimer therapy passes another important test

The Alzheimer drug candidate PRI-002 developed at Forschungszentrum Jülich has successfully completed Phase I of clinical research involving healthy volunteers. When administered daily over a period of four weeks, the active ...

Neuroscience

Do microglia hold the key to stop Alzheimer's disease?

A Leuven research team led by Prof. Bart De Strooper (VIB-KU Leuven, UK DRI) studied how specialized brain cells called microglia respond to the accumulation of toxic proteins in the brain, a feature typical of Alzheimer's. ...

Neuroscience

How fish brain cells react to Alzheimer's disease

Zebrafish, in contrast to humans, have outstanding regenerative capacities: If brain cells are lost due to illness or injury, they will easily regrow from so-called progenitor cells. With sophisticated methods, researchers ...

Medical research

A possible blood test for early-stage Alzheimer's disease

A large team of researchers affiliated with a host of institutions across South Korea has developed a possible blood test to detect the early stages of Alzheimer's disease in patients who have yet to exhibit symptoms. In ...

Alzheimer's disease & dementia

Tiny worm mimics key genetic risk for Alzheimer's

Researchers at The University of Alabama have shown a tiny worm can replicate genetic causes of Alzheimer's disease, expanding the breadth of preclinical models for the disease.

Alzheimer's disease & dementia

Neuronal cytoskeletons involved in Alzheimer's disease

A researcher at the UPV/EHU participated in a study describing the loss of dynamics and subsequent impairment of the dendritic spines in Alzheimer's disease. Dendritic spines are the compartments of neurons responsible for ...

page 1 from 17